Physician
Carient Heart & Vascular, LLC
Carient Heart & Vascular, LLC was paid $2.55M by Medicaid between Feb 2018 and Dec 2024, across 50 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 48% of everything it billed.
33Billing provider infoCARIENT HEART & VASCULAR, LLC
MANASSAS, VA 20109
MANASSAS, VA 20109
33aNPI1669982526assigned 10/05/2017
33bProvider typeCardiovascular Disease Physician
28Total paid$2.55M
24GClaims80,073
24DCodes billed50
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in Virginia
Rank by total paid#2 of 117
Median peer was paid$4K
This provider vs. median636×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,637 | $53K | |
| 2019 | 13,856 | $134K | |
| 2020 | 7,957 | $175K | |
| 2021 | 8,145 | $288K | |
| 2022 | 10,878 | $466K | |
| 2023 | 14,772 | $732K | |
| 2024incomplete | 13,828 | $699K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 48% | 28,029 | 24,589 | $1.22M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 25% | 8,121 | 7,561 | $645K |
| 78431 | 6.1% | 176 | 152 | $155K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.5% | 1,409 | 1,329 | $116K |
| 93000 | 3.2% | 12,659 | 11,322 | $83K | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 2.2% | 190 | 173 | $56K |
| J2785 | Injection, regadenoson, 0.1 mg | 1.5% | 537 | 495 | $39K |
| 93298 | 1.4% | 2,520 | 2,385 | $36K | |
| 93015 | 1.4% | 1,012 | 921 | $35K | |
| 78492 | 1.1% | 29 | 25 | $29K | |
| 93925 | <1% | 246 | 236 | $25K | |
| 93970 | <1% | 202 | 189 | $19K |
38 more codes
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 109 | $18K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 377 | $12K |
| 93296 | <1% | 1,352 | $12K | |
| 93922 | <1% | 325 | $11K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 346 | $9K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 85 | $7K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 67 | $6K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,667 | $3K |
| 93294 | <1% | 317 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 83 | $2K |
| 78434 | <1% | 35 | $2K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 88 | $2K |
| 93268 | <1% | 13 | $2K | |
| 99223 | Prolong inpt eval add15 m | <1% | 12 | $1K |
| 99490 | Ccm add 20min | <1% | 131 | $747.11 |
| 93295 | <1% | 58 | $745.22 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $536.41 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 13 | $128.88 |
| 1090F | 0% | 334 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 510 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 2,364 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 0% | 2,340 | $0.00 |
| 4040F | 0% | 1,310 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 208 | $0.00 |
| G8400 | Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given | 0% | 296 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 236 | $0.00 |
| G9900 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified | 0% | 39 | $0.00 |
| G8536 | No documentation of an elder maltreatment screen, reason not given | 0% | 1,440 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 2,309 | $0.00 |
| 1036F | 0% | 1,650 | $0.00 | |
| G8732 | No documentation of pain assessment, reason not given | 0% | 1,772 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 247 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 517 | $0.00 |
| 1101F | 0% | 1,831 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 588 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 701 | $0.00 |
| 1123F | 0% | 1,142 | $0.00 | |
| 3017F | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGHAFOURI, MERDOD (PHYSICIAN)